|
|
|
|
Serum Procalcitonin in Systemic Autoimmune DiseasesWhere Are We Now
Buhaescu I et al.Significantly elevated PCT levels offer good specificity and sensitivity for systemic infection in patients with systemic autoimmune diseases, regardless of the use of corticosteroids or immunosuppressive agents. PCT measurement may add to...
|
|
|
NIH awards over $15M for Tulane University's collaborative effort to combat VHF
Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, and Tulane University, today announced a major extension of the collaborative effort to combat viral hemorrhagic fever (VHF), an effort that...
|
|
|
NIH awards over $15M for Tulane University's collaborative effort to combat VHF
Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, and Tulane University, today announced a major extension of the collaborative effort to combat viral hemorrhagic fever (VHF), an effort that...
|
|
|
Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic
DENVER and NEW ORLEANS, Feb.8 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX.OB), a worldwide developer and marketer of diagnostic test kits, and Tulane University, today announced a major extension of the collaborative...
|
|
|
Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Developme
New study will focus on identification of novel B-cell epitopes on Lassa virus proteins that could result in novel agents to treat and prevent the disease DENVER and NEW ORLEANS, Feb.8 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC:CONX) ...
|
|
|
Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents
Companies mentioned in this article: Corgenix Medical Corporation DENVER and NEW ORLEANS, Feb.8 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, and Tulane...
|
|
|
Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Developme
Companies mentioned in this article: Corgenix Medical Corporation DENVER and NEW ORLEANS, Feb.8 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, and Tulane...
|
|
|
Reports summarize autoimmune diseases clinical trial research from Bristol-Myers Squibb Company
Today's Medical & Research News Researchers detail in 'Clinically validated approaches to the treatment of autoimmune diseases,' new data in autoimmune diseases.According to a study from the United States, 'IMPORTANCE OF THE FIELD: Autoimmune...
|
|
|
Autoimmune Diseases Clinical Trial: Reports summarize autoimmune diseases clinical trial research from Bristol-Myers Squibb Company
Today's Medical & Research News Reports summarize research from Bristol-Myers Squibb Company February 6th, 2010 Printer-Friendly Version City:Princeton State:NJ Country:United States Arthritis Autoimmune Diseases Autoimmune Disorder Crohn...
|
|
|
Cold Spring Harbor Laboratory: Novel mouse model of demyelinating disorder
Today's Medical & Research News Novel mouse model of demyelinating disorder February 5th, 2010 Printer-Friendly Version Autoimmune Disease Autoimmune Disorder Disease Infection Tumors Immunology Multiple Sclerosis Neurology Neurosurgery...
|
|
|
Autoimmune thyroiditis: A model uniquely suited to probe regulatory T cell function
Kong YCM et al.These models helped to elucidate the complex interplay between autoantigen presentation and MHC class IImediated T cell selection in the development of Treg and autoreactive T cell repertoires determining susceptibility to autoimmunity. ...
|
|
|
Multiple Sclerosis: Research from University of Tokyo provides new data about multiple sclerosis
Today's Medical & Research News Multiple Sclerosis Research from University of Tokyo provides new data about multiple sclerosis February 3rd, 2010 Printer-Friendly Version City:Tokyo Country:Japan Antiinflammatory Autoimmune Disease Autoimmune...
|
|
|
Systemic Lupus Erythematosus: Research on systemic lupus erythematosus described by scientists at University of Pecs, Department of Medical Genetics
Today's Medical & Research News Research on described by scientists at University of Pecs, Department of Medical Genetics February 3rd, 2010 Printer-Friendly Version City:Pecs Country:Hungary Ankylosing Spondylitis Arthritis Autoimmune Diseases ...
|
|
|
Antibodies Attack Immune Proteins
Two studies published online on February 1 in the Journal of Experimental Medicine reveal that patients with a rare autoimmune disease produce antibodies that attack microbe-fighting immune proteins called cytokines.These findings may help explain why these...
|
|
|
Antibodies Attack Immune Proteins
Two studies published online on February 1 in the Journal of Experimental Medicine reveal that patients with a rare autoimmune disease produce antibodies that attack microbe-fighting immune proteins called cytokines.These findings may help explain why these...
|
|
|
Autoimmune Disease: Findings from University of Sao Paulo, Rheumatology Division advance knowledge in autoimmune disease
Today's Medical & Research News Autoimmune Disease Findings from University of Sao Paulo, Rheumatology Division advance knowledge in autoimmune disease February 2nd, 2010 Printer-Friendly Version City:Sao Paulo Country:Brazil Allergies Allergy...
|
|
|
Compugen Discovers Novel Protein for Treatment of Autoimmune Diseases
CGEN-15001 demonstrates potent decrease in disease state in multiple sclerosis animal model Novel parent molecule was both discovered, and predicted to be member of the B7/CD28 co-stimulatory protein family, through use of in silico LEADS Platform TEL AVIV,...
|
|
|
Compugen Discovers Novel Protein for Treatment of Autoimmune Diseases
CGEN-15001 demonstrates potent decrease in disease state in multiple sclerosis animal model Novel parent molecule was both discovered, and predicted to be member of the B7/CD28 co-stimulatory protein family, through use of in silico LEADS Platform TEL AVIV,...
|
|
|
Compugen Discovers Novel Protein for Treatment of Autoimmune Diseases
Compugen Ltd.(NASDAQ: CGEN) announced today the discovery and experimental validation of CGEN-15001 for the treatment of autoimmune disorders. CGEN-15001 is the extracellular region of a previously unknown membrane protein in the B7/CD28 family. The...
|
|
|
Antibodies attack immune proteins
Two studies published online on February 1 in the Journal of Experimental Medicine (www.jem.org) reveal that patients with a rare autoimmune disease produce antibodies that attack microbe-fighting immune proteins called cytokines.These findings may help...
|
|
|
Autoantibodies to Insulin, Insulinoma-Associated Antigen-2, and Zinc Transporter 8 Improve the Prediction of Early Insulin Requirement in Adult-Onset Autoimmune Diabetes
Kawasaki E et al.Autoantibodies to Insulin, Insulinoma-Associated Antigen-2, and Zinc Transporter 8 Improve the Prediction of Early Insulin Requirement in Adult-Onset Autoimmune Diabetes.
|
|
|
Autoimmune pancreatitis: An underdiagnosed autoimmune disease with clinical, imaging and serological features
SanchezCastanon M et al.Clinical manifestations are related with pancreas dysfunction but other organs may be affected such as bile duct, gallbladder, salivary gland, retroperitoneum, kidney, lung and prostate. Autoimmune pancreatitis: An...
|
|
|
Patients with rare autoimmune disease produce antibodies that disarm immune proteins
Two studies published online on February 1 in the Journal of Experimental Medicine (www.jem.org) reveal that patients with a rare autoimmune disease produce antibodies that attack microbe-fighting immune proteins called cytokines.These findings may help...
|
|
|
Antibodies attack immune proteins
Two studies published online on February 1 in the Journal of Experimental Medicine reveal that patients with a rare autoimmune disease produce antibodies that attack microbe-fighting immune proteins called cytokines.These findings may help explain why these...
|
|
|
Antibodies attack immune proteins
Two studies published online on February 1 in the Journal of Experimental Medicine (www.jem.org) reveal that patients with a rare autoimmune disease produce antibodies that attack microbe-fighting immune proteins called cytokines.These findings may help...
|
